Literature DB >> 3382760

Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.

G Gamba1, S B Solerte, G Grignani, L Pacchiarini, N Montani, E Ferrari.   

Abstract

The relationship among blood lipids, haemostatic and fibrinolytic parameters have been evaluated, during a follow-up study, in 27 non-insulin dependent (type II) diabetic patients. Upon recruitment, and in periodical controls, we observed that plasma triglycerides and VLDL levels correlated inversely, and HDL directly, with the fibrinolytic activity of plasma and euglobulin precipitate. Furthermore triglycerides and VLDL correlated directly with Factor VIII antigen (vWFAg). After 5 years in the study, 12 patients (44%) had macroangiopathic complications, and 9 of these subjects showed persistently high levels of triglycerides (above 2.36 mmol/l). These haemostatic and lipid components, however, do not influence the progression of diabetic retinopathy and nephropathy. The alterations of lipid, haemostatic and fibrinolytic parameters and their possible relationships seem to play an important role in the occurrence of diabetic macroangiopathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382760     DOI: 10.1007/bf00320285

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  27 in total

1.  The determination of plasma fibrinogen by the clot-weight method.

Authors:  I C INGRAM
Journal:  Biochem J       Date:  1952-08       Impact factor: 3.857

2.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

3.  Platelets and diabetes mellitus.

Authors:  J F Mustand; M A Packham
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

Review 4.  New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.

Authors:  J A Colwell; P D Winocour; M Lopes-Virella; P V Halushka
Journal:  Am J Med       Date:  1983-11-30       Impact factor: 4.965

5.  Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complications.

Authors:  G Grignani; G Gamba; D Geroldi; L Pacchiarini; B Solerte; E Ferrari; E Ascari
Journal:  Thromb Haemost       Date:  1981-10       Impact factor: 5.249

6.  Glucose inhibits replication of cultured human endothelial cells.

Authors:  R W Stout
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

7.  Hypertriglyceridaemia and hypercoagulability.

Authors:  H C Simpson; J I Mann; T W Meade; R Chakrabarti; Y Stirling; L Woolf
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

8.  In vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serum.

Authors:  B W Arbogast; G M Lee; T L Raymond
Journal:  Diabetes       Date:  1982-07       Impact factor: 9.461

9.  Fibrinogen as a risk factor for stroke and myocardial infarction.

Authors:  L Wilhelmsen; K Svärdsudd; K Korsan-Bengtsen; B Larsson; L Welin; G Tibblin
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

10.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

Authors:  A Hamsten; B Wiman; U de Faire; M Blombäck
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.